Gastrointestinal Cancer News

ASCO released updated recommendations that incorporate new evidence related to second-line therapy for patients with metastatic pancreatic cancer who progressed on or experienced intolerable toxicity during first-line therapy.

Researchers have linked prediagnostic markers of inflammation with an increased risk for esophageal adenocarcinoma, according to a study published in Gut.

Patients with interval colorectal cancers have a similar risk for mortality as patients with clinically detected colorectal cancers, according to research published in Gastroenterology.

In August, the FDA issued several approvals and review designations across the field of oncology. HemOnc Today has compiled a list of the past month’s approvals, updates and submissions.

Medical and surgical treatment of gastroesophageal reflux disease showed similar reductions in risk for esophageal adenocarcinoma, according to findings from a population-based cohort study.

In 2015, oropharyngeal squamous cell carcinoma surpassed cervical cancer as the most common HPV-associated cancer in the U.S., with 15,479 cases among men and 3,438 cases among women, according to data from the CDC published in Morbidity and Mortality Weekly Report.

Patients from minority communities are less likely to receive a recommendation for genetic evaluation or undergo genetic testing for Lynch syndrome, according to research published in Clinical Gastroenterology and Hepatology.

Liver disease researchers recently published internally validated models that estimated the risk for hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C based on the presence of cirrhosis and sustained virologic response outcome.

The use of screening tests for breast, cervical and colorectal cancer in 2015 remained below Healthy People 2020 targets, according to data recently published in Preventing Chronic Disease.

The American College of Radiology Liver Imaging Reporting and Data System steering committee developed and approved a new version of the CT/MRI LI-RADS — a comprehensive system for standardizing the acquisition, interpretation, reporting and data collection of liver imaging — according to a press release.